RI
RTW Investments Portfolio holdings
AUM
$8.12B
1-Year Est. Return
73.2%
1 Year Est. Return
+73.2%
AUM
$8.12B
AUM Growth
+$1.09B
(+16%)
Holding
83
Top Buys
| 1 | +$76.4M | |
| 2 | +$49.8M | |
| 3 | +$46.6M | |
| 4 |
Xencor
XNCR
|
+$44.8M |
| 5 |
Guardant Health
GH
|
+$39M |
Top Sells
| 1 | +$289M | |
| 2 | +$186M | |
| 3 | +$110M | |
| 4 |
Natera
NTRA
|
+$95.6M |
| 5 |
Alkermes
ALKS
|
+$90.3M |
Sector Composition
| 1 | Healthcare | 99.9% |
| 2 | Financials | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Madrigal Pharmaceuticals
MDGL
$13.2B
| $914M | 11.27% |
1,993,687
|
|
||
2
argenx
ARGX
$55.1B
| $497M | 6.12% |
673,497
|
|
||
3
Avidity Biosciences
RNA
$10.8B
| $496M | 6.11% |
11,372,829
+1,753,984
|
|
||
4
PTC Therapeutics
PTCT
$6.36B
| $475M | 5.86% |
7,746,415
|
|
||
5
Insmed
INSM
$45.1B
| $444M | 5.47% |
3,084,558
|
|
||
6
Protagonist Therapeutics
PTGX
$5.35B
| $382M | 4.71% |
5,756,277
|
|
||
|
7
Natera
NTRA
$32.3B
| $322M | 3.97% |
2,000,000
-593,645
|
|
||
8
Akero Therapeutics
AKRO
$4.48B
| $260M | 3.2% |
5,477,561
|
|
||
9
uniQure
QURE
$1.66B
| $258M | 3.18% |
4,424,968
-733,263
|
|
||
10
Penumbra
PEN
$11.4B
| $220M | 2.7% |
866,499
+2,946
|
|
||
11
RadNet
RDNT
$6.17B
| $215M | 2.64% |
2,815,544
+125,200
|
|
||
12
Merus
MRUS
$7.28B
| $191M | 2.35% |
2,025,277
-1,975,276
|
|
||
13
Tarsus Pharmaceuticals
TARS
$3.39B
| $189M | 2.33% |
3,177,436
+65,756
|
|
||
14
Stryker
SYK
$142B
| $181M | 2.23% |
490,000
-100,517
|
|
||
15
Immunocore
IMCR
$1.9B
| $177M | 2.18% |
4,869,798
|
|
||
16
Acadia Pharmaceuticals
ACAD
$4.2B
| $152M | 1.88% |
7,144,524
-1,851,023
|
|
||
17
Cytokinetics
CYTK
$8.08B
| $150M | 1.84% |
2,721,158
|
|
||
18
Neurocrine Biosciences
NBIX
$15B
| $149M | 1.84% |
1,062,072
|
|
||
19
Axsome Therapeutics
AXSM
$7.51B
| $136M | 1.67% |
1,118,883
-398,020
|
|
||
20
Stoke Therapeutics
STOK
$1.72B
| $120M | 1.48% |
5,123,525
|
|
||
21
Apogee Therapeutics
APGE
$4.71B
| $108M | 1.33% |
2,712,097
|
|
||
22
Establishment Labs
ESTA
$1.97B
| $106M | 1.31% |
2,588,831
+4,700
|
|
||
23
Masimo
MASI
$7.74B
| $101M | 1.24% |
683,294
|
|
||
24
Ultragenyx Pharmaceutical
RARE
$3.22B
| $98M | 1.21% |
3,258,266
+1,550,864
|
|
||
|
25
Guardant Health
GH
$13.7B
| $92.5M | 1.14% |
1,481,033
+624,532
|
|